These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38875509)

  • 1. Good Treatment of Hyperacute Intracerebral Hemorrhage Is as Easy as ABC.
    Seiffge DJ
    Neurology; 2024 Jul; 103(2):e209614. PubMed ID: 38875509
    [No Abstract]   [Full Text] [Related]  

  • 2. MISTIE III.
    Cordonnier C; Tymianski M
    Stroke; 2019 Jun; 50(6):1634-1635. PubMed ID: 31084319
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolysis for intraventricular hemorrhage.
    Wong RH; Bailes JE
    Semin Thromb Hemost; 2013 Jun; 39(4):400-5. PubMed ID: 23446915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.
    Rao NM; Levine SR; Gornbein JA; Saver JL
    Stroke; 2014 Sep; 45(9):2728-33. PubMed ID: 25096731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.
    Carlson SE; Aldrich MS; Greenberg HS; Topol EJ
    Arch Neurol; 1988 Oct; 45(10):1070-3. PubMed ID: 3140769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits].
    Schaller C; Rohde V; Hassler W
    Nervenarzt; 1995 Oct; 66(10):792. PubMed ID: 7501098
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to letter regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".
    Rao NM; Levine SR; Saver JL
    Stroke; 2015 Feb; 46(2):e45. PubMed ID: 25572410
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by turc et Al regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".
    Turc G; Tisserand M; Seners P; Oppenheim C; Baron JC
    Stroke; 2015 Feb; 46(2):e43-4. PubMed ID: 25572409
    [No Abstract]   [Full Text] [Related]  

  • 10. Multimodal treatment of post-tissue plasminogen activator-related intracerebral haemorrhage.
    Varma D; Chen C; McDonald M; Lee A
    Intern Med J; 2012 Feb; 42(2):220-2. PubMed ID: 22356500
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraventricular hemorrhage in adults: complications and treatment.
    Naff NJ; Tuhrim S
    New Horiz; 1997 Nov; 5(4):359-63. PubMed ID: 9433988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.
    Newell DW; Shah MM; Wilcox R; Hansmann DR; Melnychuk E; Muschelli J; Hanley DF
    J Neurosurg; 2011 Sep; 115(3):592-601. PubMed ID: 21663412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Represses Symptomatic Intracerebral Hemorrhage after Recombinant Tissue Plasminogen Activator Therapy by Promoting Transforming Growth Factor-β1.
    Chen J; Bai Q; Zhao Z; Sui H; Xie X
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):549-55. PubMed ID: 26683593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
    Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
    Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
    Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator.
    Schaller C; Rohde V; Meyer B; Hassler W
    Neurosurgery; 1995 Feb; 36(2):328-33; discussion 333-5. PubMed ID: 7731513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis with tissue plasminogen activator: protocol violation is not an option.
    Kumar S
    Neurol India; 2007; 55(2):174; author reply 174-5. PubMed ID: 17558129
    [No Abstract]   [Full Text] [Related]  

  • 19. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.
    Brown DL; Barsan WG; Lisabeth LD; Gallery ME; Morgenstern LB
    Ann Emerg Med; 2005 Jul; 46(1):56-60. PubMed ID: 15988427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage.
    Hua Y; Xi G; Keep RF; Wu J; Jiang Y; Hoff JT
    J Cereb Blood Flow Metab; 2002 Jan; 22(1):55-61. PubMed ID: 11807394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.